Sixfold Bioscience

Delivering RNA therapies.

Sixfold Bioscience was founded in 2018, is headquartered in London, United Kingdom, lists 11–50 employees, and has $10.5M in recorded funding across 1 round.

Headquarters
London
Employees
11–50
Founded
2018
Total Funding
$10.5M
Last Round
$10.5M SeedDec 2021
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 4 investors for this company. The full record is or through the API.

About

Sixfold Bioscience develops programmable delivery systems for RNA therapeutics, with a focus on short interfering RNA for gene silencing and messenger RNA for gene expression. Its Mergo platform combines RNA therapeutics with biocompatible building blocks designed to target selected cell types. Sixfold computationally screens those building blocks, assembles them using high-throughput chemistry, and tests each iteration to improve delivery to a given tissue.

Summary

Sixfold Bioscience is a Biotech company based in London, United Kingdom, founded in 2018. It lists 11–50 employees. It has raised $10.5M in total across 1 round, most recently a $10.5M Seed round in Dec 2021. Investors include Cantos, Lombard Street Ventures and Pi Campus.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundDec 2021
$10.5M

Investors

Similar Companies

Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series BTotal funding$612.0MOct 2022
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sixfold Bioscience on Indexed.vc
<a href="https://indexed.vc/companies/sixfoldbioscience"><img src="https://indexed.vc/api/badge/company/sixfoldbioscience" alt="Sixfold Bioscience on Indexed.vc" width="260" height="76" /></a>